Private Trust Co. NA Acquires 160 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Private Trust Co. NA raised its stake in HCA Healthcare, Inc. (NYSE:HCA) by 16.4% during the third quarter, HoldingsChannel reports. The institutional investor owned 1,137 shares of the company’s stock after acquiring an additional 160 shares during the period. Private Trust Co. NA’s holdings in HCA Healthcare were worth $462,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in HCA. Bangor Savings Bank lifted its position in shares of HCA Healthcare by 112.5% in the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after purchasing an additional 45 shares during the period. MFA Wealth Advisors LLC bought a new stake in HCA Healthcare during the second quarter valued at $27,000. Unique Wealth Strategies LLC bought a new position in shares of HCA Healthcare in the 2nd quarter worth about $28,000. GPS Wealth Strategies Group LLC grew its stake in HCA Healthcare by 284.0% during the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after purchasing an additional 71 shares during the period. Finally, Benjamin F. Edwards & Company Inc. acquired a new position in HCA Healthcare in the second quarter valued at approximately $33,000. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Trading Down 1.1 %

NYSE HCA opened at $325.35 on Thursday. HCA Healthcare, Inc. has a one year low of $245.84 and a one year high of $417.14. The business’s fifty day moving average is $374.98 and its 200-day moving average is $358.51. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. The stock has a market capitalization of $82.41 billion, a price-to-earnings ratio of 14.61, a PEG ratio of 1.25 and a beta of 1.68.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be given a dividend of $0.66 per share. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 annualized dividend and a yield of 0.81%. HCA Healthcare’s payout ratio is presently 11.85%.

Insider Buying and Selling

In other news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. The trade was a 21.97 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the sale, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at $18,445,700. The trade was a 6.89 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 15,155 shares of company stock worth $5,608,990. Corporate insiders own 1.70% of the company’s stock.

Analyst Ratings Changes

HCA has been the topic of a number of research reports. Cantor Fitzgerald reiterated an “overweight” rating and set a $392.00 target price on shares of HCA Healthcare in a research report on Tuesday, October 1st. TD Cowen reduced their target price on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research note on Monday, October 28th. Wells Fargo & Company lowered HCA Healthcare from an “equal weight” rating to an “underweight” rating and cut their price target for the stock from $400.00 to $320.00 in a report on Monday. Truist Financial upped their target price on HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a research report on Monday, August 19th. Finally, StockNews.com lowered shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $380.29.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.